TABLE 2.
Urban | Rural | p Value | |
---|---|---|---|
n (%) | n (%) | ||
ASXL1 | 2 (2%) | 4 (5.9%) | .2362 |
DNMT3a | 19 (20%) | 9 (13.2%) | .2589 |
IDH1 | 5 (5.3%) | 4 (5.9%) | 1.0000 |
IDH2 | 6 (6.3%) | 2 (2.9%) | .4705 |
NPM1 | 18 (19%) | 9 (13.2%) | .3334 |
NRAS | 7 (7.4%) | 4 (5.9%) | .7634 |
TET2 | 3 (3.2%) | 1 (1.5%) | .6411 |
TP53 | 4 (4.2%) | 5 (7.4%) | .4924 |
FLT3 | 8 (8.4%) | 7 (10.3%) | .6833 |
Note: This table describes the mutation frequency stratified by area of residency (urban or rural). There was no statistically significant difference in the frequency of any mutations between the cohorts. FLT3 incorporates both internal tandem duplication and tyrosine kinase domain mutations.